
Ben Lamm
PersonHeard in 16 episodes across 6 shows since May 2026
Ben Lamm is an entrepreneur and the co-founder and CEO of Colossal Biosciences, a biotechnology company focused on de-extinction. He is also known for his leadership roles at Astromech and other technology ventures.
Episodes
First heard
Guest appearances
Episodes per month
Public PodLume episodes featuring it, over the last year.
Show the data
| Month | Episodes |
|---|---|
| Dec 2025 | 0 |
| Jan 2026 | 0 |
| Feb 2026 | 0 |
| Mar 2026 | 0 |
| Apr 2026 | 0 |
| May 2026 | 1 |
| Jun 2026 | 0 |
| Jul 2026 | 0 |
| Aug 2026 | 3 |
| Sep 2026 | 3 |
| Oct 2026 | 8 |
| Nov 2026 | 1 |
Email alert
Email me when Ben Lamm comes up on a podcast
One email a week at most, with the new episodes that mention Ben Lamm. Free, no account needed, unsubscribe in one click.
What Ben Lamm has said on podcasts
32 statements
Colossal is making good progress on its mammoth project.
“we are not working on that currently. Um, but we're making good progress on the mammoth project”
Open the episode · Why We're Living in a Biological Singularity With Ben Lamm | MOONSHOTS Live #297Listen at 1:18
George Church is arguably synthetic biology’s father and heads genetics at Harvard.
“George is the father of— arguably the father of synthetic biology. He's the head of genetics at Harvard.”
Open the episode · Why We're Living in a Biological Singularity With Ben Lamm | MOONSHOTS Live #297Listen at 3:37
Replicating published biological experiments can produce 40–60% failure rates.
“you're going to get like somewhere between 40% and 60% failure rate on published work”
Open the episode · Why We're Living in a Biological Singularity With Ben Lamm | MOONSHOTS Live #297Listen at 6:49
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
16 episodes featuring Ben Lamm, newest first
- Nov 12, 2026
Paleontologist explains how science proves dinosaurs were realThe Joe Rogan ExperienceNov 12, 2026 - Oct 31, 2026
AI’s infrastructure race collides with markets, labor and human purposeMoonshots with Peter DiamandisOct 31, 2026 - Oct 28, 2026
AI’s convergence tests Europe, markets and human controlMoonshots with Peter DiamandisOct 28, 2026 - Oct 26, 2026
AI agents challenge banks as gene-edited dogs enter defense debateMorning Brew DailyOct 26, 2026 - Oct 23, 2026
Moderna’s cancer data sparks a market frenzy and bigger questionsTBPNOct 23, 2026 - Oct 23, 2026
SpaceX pivots toward AI infrastructure as agents test their limitsMoonshots with Peter DiamandisOct 23, 2026